CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- 4 Derivatives Options or other derivatives
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 4 Option exercise Chief Financial Officer acquired 35,868 shares (option exercise)
- 4 Option exercise Chief Operating Officer acquired 30,960 shares (option exercise)
- 4 Option exercise SVP, IP Affairs acquired 37,756 shares (option exercise)
- 4 Option exercise Chief Legal Officer acquired 43,419 shares (option exercise)
- 4 Option exercise President and CEO acquired 283,173 shares (option exercise)
- 4 Grant or award Director acquired 42,735 shares (grant or award)
- 4 Grant or award Director acquired 85,470 shares (grant or award)
- 4 Grant or award Director acquired 48,290 shares (grant or award)
- 4 Grant or award Director acquired 26,923 shares (grant or award)
- 4 Grant or award Director acquired 53,418 shares (grant or award)
- 4 Grant or award Director acquired 48,290 shares (grant or award)
- 4 Grant or award Director acquired 58,974 shares (grant or award)
- 4 Grant or award Director acquired 48,290 shares (grant or award)
- 4 Grant or award Director acquired 53,418 shares (grant or award)
- 8-K Event Regulation FD disclosure
Page 15 of 67 · 1,325 filings